Q: The Globe Investor has the target price on PBH as $106.50 based on analysts polled by Zacks Investment Research (6 month time horizon, updated daily). On BNN yesterday, the caller asked for the street consensus target, which was $116.50. Pretty large difference = $10. Is it simply the 6 month target price vs a 12 month target price? Thanks...Steve
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: You have a knack for picking takeovers - ( Thank you very much ) Can you list a few of your existing takeover bets ? Thanx Robbie
Q: I looked at PUR, liked the business, but found it pricey and chose to wait. A bad call I suppose. I realize Xylem will realize cost savings on the acquisition, and will no doubt see opportunities to expand PUR's business within its portfolio, but please help me understand something. I estimate Xylem is paying over 20 times PUR's expected 2017 EBITDA. I thought 10 to 11 times was "high". Isn't $9.00 exceptionally pricey? What can I take away from this? Thank you for your time. Edward.
Q: Hello Peter and Team,
I do like BCI quite a bit as people need glasses. It's one of those boring areas of the market that is a necessity. A couple questions though:
Would BCI be considered a staple or a discretionary stock? I feel like it should be a staple as vision is not something I would forgo.
As well, in your report there isn't any mention of how laser surgery is affecting a market. I do know quite a few people that have undergone laser surgery and who widely recommend it to others. How much is laser surgery affecting the marketplace? And how is cheap alternatives online affecting the marketplace?
Thank you for your great service as always!
Wes
I do like BCI quite a bit as people need glasses. It's one of those boring areas of the market that is a necessity. A couple questions though:
Would BCI be considered a staple or a discretionary stock? I feel like it should be a staple as vision is not something I would forgo.
As well, in your report there isn't any mention of how laser surgery is affecting a market. I do know quite a few people that have undergone laser surgery and who widely recommend it to others. How much is laser surgery affecting the marketplace? And how is cheap alternatives online affecting the marketplace?
Thank you for your great service as always!
Wes
Q: I currently hold a 3% position on the baby, and has dropped to 2% in my RRSP. I am seriously question where this is going, have you any concerns, should I be seriously considering taking a loss and stepping out.
Your candid comments are appreciated.
Your candid comments are appreciated.
Q: Hello team,
HLF been selected as one of the "graham stocks" for 2018.
Do you agree with the views and worth owning the stock?
Thanks
HLF been selected as one of the "graham stocks" for 2018.
Do you agree with the views and worth owning the stock?
Thanks
Q: Hi peter is the downward pressure on this stock related to tax loss selling ?
Kind regards
Stan
Kind regards
Stan
Q: Just a note of thanks for your service. The take-over of PUR today is another reminder as to why I subscribe. This is a company that I doubt I would have come across on my own and it's turned in to a big win in my portfolio.
Q: In the December 5th, 2017 press release, DHX stated that:
"in connection with its strategic review process, it has received Toronto Stock Exchange (“TSX”) approval to delay the holding of its annual general meeting to a date which will be no later than February 27, 2018."
In your experience, does this imply news is to come? or is it just a normal proceeding for companies in this situation?
Further, would there be any compelling case to obtain a position in this stock after tax-loss selling season?
Thanks!
"in connection with its strategic review process, it has received Toronto Stock Exchange (“TSX”) approval to delay the holding of its annual general meeting to a date which will be no later than February 27, 2018."
In your experience, does this imply news is to come? or is it just a normal proceeding for companies in this situation?
Further, would there be any compelling case to obtain a position in this stock after tax-loss selling season?
Thanks!
Q: I need to take a loss what would you swap to to stay in the oil sector.
Q: Why would Sylogist not graduate to the TSE in order to get better exposure? And would you consider syz in the saas area as CSU, DSG and Kinaxis. And would they rank last and would they be an attractive takeover target by a bigger company.
Q: Earlier today you suggested a hold for now. In that another offer is a slim hope and therefore there is little room for any more appreciation why not sell now and put the money some where with more potential? Thanks
Q: Great news with Pure Technologies. What is the expected date for this deal to close?
Q: I have PUR in a non registered account. With the acquisition by an American company, for tax purposes would it be best to just sell at the higher price (to avoid US paper work)?
thanks,
Paul
thanks,
Paul
Q: Good morning Gentlemen.
I need to re-balance my Industrial sector.
Actual holdings BAD 1%, ATA 1.5%, SIS 3.3%, and WSP 3.4%.
By selling BAD (1%) I will have 5% to add to the sector.
Can you please suggest 2 or 3 Can or US solid mid-cap stocks for at least 5 years.
Thanks
Best Regards
I need to re-balance my Industrial sector.
Actual holdings BAD 1%, ATA 1.5%, SIS 3.3%, and WSP 3.4%.
By selling BAD (1%) I will have 5% to add to the sector.
Can you please suggest 2 or 3 Can or US solid mid-cap stocks for at least 5 years.
Thanks
Best Regards
Q: What do you think of the acquisition by Xylem?
Q: Hi team,
CPX appears to be a great company but technically never been able to break out above $25 to $26 dollar range.
Can we expect anything different?
Thanks for your reply.
CPX appears to be a great company but technically never been able to break out above $25 to $26 dollar range.
Can we expect anything different?
Thanks for your reply.
Q: GUD How is Jonathan Goodman's health. What is his age ? Does he have good people around him or does he make all the decisions ? Any insider buying ? RAK
Q: I have to sell some of my shares in my registered LIF Account by the end of the year. Which of the two mentioned above should I lighten up on. XCB looks flat and has only a small dividend. I would prefer to keep my CSH.UN for long term.
What is your opinion and reasoning.
Thank you!
What is your opinion and reasoning.
Thank you!
Q: I am retired living on dividend income. Been considering starting a position in FSZ for a few months for the good yield and growth potential. Do you think this dip is a good time to start a position?
Or would you wait to see how they use the net proceeds of the recent offerings?
Or would you wait to see how they use the net proceeds of the recent offerings?